Built to sell – can dealmaker Cathal Friel build (and sell) a £80m company in two years? February 24, 2020 – Posted in: Open Orphan (ORPH)

by Sean Keyes | Financial Correspondant Serial dealmaker Cathal Friel has an audacious plan: build and sell a pharma services company in two years. It could fetch as much as £100 million. What exactly is his plan? And will it work? On the cover of the fifth edition of Dr John Oxford’s book Human Virology is a picture of the Wuhan strain of the coronavirus. It was published in 2016. The virus spherical, with hundreds…

Continue reading